NCT07851896

Brief Summary

This study aims to investigate the effects of Basic Body Awareness Therapy combined with aerobic exercise on inflammatory biomarkers (interleukin-6 and cortisol), cognitive functions, and depression levels in women diagnosed with fibromyalgia syndrome. Participants will be randomly assigned to an intervention group receiving aerobic exercise plus Basic Body Awareness Therapy or a control group receiving aerobic exercise alone. Clinical, biochemical, cognitive, and psychological assessments will be conducted at baseline and after the intervention period. The findings are expected to contribute to evidence-based non-pharmacological rehabilitation approaches for fibromyalgia management.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
13mo left

Started Oct 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2025

Completed
9 months until next milestone

First Posted

Study publicly available on registry

October 1, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

October 15, 2026

Expected
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2027

5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2027

Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

8 months

First QC Date

December 22, 2025

Last Update Submit

September 25, 2026

Conditions

Keywords

Basic Body Awareness; Fibromyalgia; Exercise; Cortisol; Interleukin-6

Outcome Measures

Primary Outcomes (2)

  • Interleukin-6 (IL-6)

    Changes in serum interleukin-6 (IL-6) concentration will be assessed using standardized laboratory assay methods to evaluate the biological effects of aerobic exercise with or without Basic Body Awareness Therapy in women with fibromyalgia.

    Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.

  • Cortisol

    Changes in cortisol concentration will be assessed using standardized laboratory assay methods to evaluate the biological effects of aerobic exercise with or without Basic Body Awareness Therapy in women with fibromyalgia.

    Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.

Secondary Outcomes (7)

  • Cognitive Function Assessed by Trail Making Test

    Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.

  • Depression Level Measured by Depression Anxiety Stress Scale-21 (DASS-21) Depression Subscale

    Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.

  • Pain Intensity Measured by Visual Analog Scale (VAS)

    Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.

  • Pressure Pain Threshold Measured by Pressure Algometer

    Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.

  • Fibromyalgia Disease Severity Assessed by Revised Fibromyalgia Impact Questionnaire (FIQR)

    Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.

  • +2 more secondary outcomes

Study Arms (2)

Aerobic Exercise + Basic Body Awareness Therapy

EXPERIMENTAL

Participants in this group will receive a supervised moderate-intensity aerobic exercise program combined with Basic Body Awareness Therapy. The aerobic exercise program will be administered according to standardized protocols, and Basic Body Awareness Therapy will be applied as an adjunct intervention focusing on posture, movement quality, breathing, and body awareness. The intervention will be conducted over the predefined study period under the supervision of a physiotherapist.

Behavioral: Basic Body Awareness Therapy

Aerobic Exercise Only

EXPERIMENTAL

Participants in this group will receive a supervised moderate-intensity aerobic exercise program according to standardized protocols. No additional therapeutic interventions will be applied. The intervention will be conducted over the predefined study period under the supervision of a physiotherapist.

Behavioral: Moderate-Intensity Aerobic Exercise

Interventions

Basic Body Awareness Therapy is a physiotherapy-based intervention focusing on movement awareness, posture, balance, breathing, and body perception. The therapy aims to improve movement quality and bodily awareness through guided exercises performed in standing, sitting, and lying positions. Sessions are conducted by a trained physiotherapist according to standardized principles of Basic Body Awareness Therapy.

Also known as: BBAT
Aerobic Exercise + Basic Body Awareness Therapy

Moderate-intensity aerobic exercise consists of structured physical activity designed to improve cardiovascular endurance. Exercise intensity is prescribed and monitored according to standardized guidelines. The program is supervised by a physiotherapist and performed regularly throughout the intervention period.

Also known as: Aerobic exercise training
Aerobic Exercise Only

Eligibility Criteria

Age30 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study is restricted to female participants, as fibromyalgia predominantly affects women and gender-related biological and psychosocial differences may influence inflammatory markers, cortisol response, and treatment outcomes.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female participants aged 30 to 50 years
  • Diagnosed with fibromyalgia according to established diagnostic criteria
  • Presence of fibromyalgia-related symptoms for at least 3 months
  • Physically inactive according to the International Physical Activity Questionnaire (IPAQ) - Short Form (weekly physical activity level \< 600 MET-min/week)
  • Willingness to participate voluntarily in the exercise program twice per week for 12 weeks
  • Ability to understand study procedures and provide written informed consent

You may not qualify if:

  • Presence of any central or peripheral nervous system disease
  • Presence of progressive neurological disorders
  • Uncontrolled hypertension
  • Presence of cardiovascular disease or pathology
  • Use of psychotropic medications within the past 1 month
  • Presence of any musculoskeletal disorder other than fibromyalgia
  • Pregnancy
  • Presence of cognitive impairment that may affect cooperation or compliance with study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

FibromyalgiaMotor Activity

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesBehavior

Central Study Contacts

Hacer ÖNEN TEKİN, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This study is conducted as an open-label trial. Due to the nature of the interventions (aerobic exercise and Basic Body Awareness Therapy), blinding of participants, care providers, and investigators is not feasible. All participants and researchers are aware of group allocation throughout the study period.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of two parallel groups. The intervention group will receive moderate-intensity aerobic exercise combined with Basic Body Awareness Therapy, while the control group will receive moderate-intensity aerobic exercise only. Outcomes will be assessed at baseline and after the intervention period.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

December 22, 2025

First Posted

October 1, 2026

Study Start (Estimated)

October 15, 2026

Primary Completion (Estimated)

June 15, 2027

Study Completion (Estimated)

November 15, 2027

Last Updated

October 1, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared. The study is a single-center, thesis-based academic research project, and data sharing is not planned beyond aggregate results reported in scientific publications, in accordance with ethics committee approval and participant consent.